Tuning the Cytotoxicity of Bis-Phosphino-Amines Ruthenium(II) Para-Cymene Complexes for Clinical Development in Breast Cancer

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2021, NOVEL THERAPEUTIC AGENTS

Domínguez-Jurado E, Cimas FJ, Castro-Osma JA, Juan A, Lara-Sánchez A, Rodríguez-Diéguez A, Shafir A, Ocaña A, Alonso-Moreno CPharmaceutics. 2021 Sep...

Clinical considerations for the design of PROTACs in cancer

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS

Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Mol Cancer. 2022 Mar 7;21(1):67. PMID: 35249548; PMCID: PMC8900451....

A bis(pyrazolyl)methane derivative against clinical Staphylococcus aureus strains isolated from otitis externa

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2022, NOVEL THERAPEUTIC AGENTS

Ocaña AV, Aguilera-Correa JJ, Domínguez-Jurado E, Pérez-Martínez FC, Pérez-Tanoira R, López-Carretero Y, Masiá-Mondejar J, Castro-Osma JA, Esteban J, Alonso-Moreno C, Molina-Alarcón M, Seguí P. Laryngoscope Investig Otolaryngol. 2022 Jan 18;7(1):283-290. doi:...

Synthesis, characterization, and antibacterial activities of a heteroscorpionate derivative platinum complex against methicillin-resistant Staphylococcus aureus

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2023, NOVEL THERAPEUTIC AGENTS

Nam-Cha SH, Domínguez-Jurado E, Tinoco-Valencia SL, Pérez-Tanoira R, Morata-Moreno N, Alfaro-Ruiza R, Lara-Sánchez A, Esteban J, Luján R, Alonso-Moreno C, Seguí P, Ocaña A, Gónzalez ÁL, Aguilera-Correa JJ, Pérez-Martínez FC, Alarcón MM.Front Cell Infect Microbiol....

Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2023, NOVEL THERAPEUTIC AGENTS

del Campo-Balguerías A, Parra-Cadenas B, Nieto-Jimenez C, Bravo I, Ripoll C, Poyatos-Racionero E, Gancarski P, Carrillo-Hermosilla F, Alonso-Moreno C, Ocaña A. International Journal of Molecular Sciences 2023; 24(18):13820....

Evaluation of Heteroscorpionate Ligands as Scaffolds for the Generation of Ruthenium(Ii) Metallodrugs in Breast Cancer Therapy

Development of new chemical entities, JOURNAL ARTICLES, JOURNAL ARTICLES 2024, NOVEL THERAPEUTIC AGENTS

Domínguez-Jurado E, Ripoll C, Lara-Sánchez A, Ocaña A, Vitórica-Yrezábal IJ, Bravo I, Alonso-Moreno C.J Inorg Biochem. 2024...